Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 12 studies | 19% ± 4% | |
non-classical monocyte | 11 studies | 25% ± 11% | |
classical monocyte | 7 studies | 25% ± 8% | |
endothelial cell | 7 studies | 19% ± 2% | |
plasma cell | 5 studies | 25% ± 7% | |
plasmacytoid dendritic cell | 4 studies | 21% ± 5% | |
neutrophil | 3 studies | 18% ± 2% | |
pancreatic A cell | 3 studies | 29% ± 8% | |
type B pancreatic cell | 3 studies | 31% ± 10% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 1% | |
conventional dendritic cell | 3 studies | 29% ± 9% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
epithelial cell | 3 studies | 30% ± 2% | |
fibroblast | 3 studies | 19% ± 2% | |
monocyte | 3 studies | 21% ± 3% | |
ciliated cell | 3 studies | 28% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 528.29 | 1444 / 1445 | 99% | 3.01 | 181 / 183 |
prostate | 100% | 836.14 | 245 / 245 | 95% | 3.83 | 478 / 502 |
lung | 100% | 909.50 | 577 / 578 | 95% | 2.61 | 1101 / 1155 |
breast | 100% | 915.46 | 459 / 459 | 95% | 3.01 | 1063 / 1118 |
stomach | 100% | 605.61 | 359 / 359 | 95% | 2.64 | 271 / 286 |
pancreas | 100% | 629.21 | 328 / 328 | 94% | 2.39 | 167 / 178 |
thymus | 100% | 697.02 | 652 / 653 | 93% | 2.59 | 563 / 605 |
ovary | 100% | 572.60 | 180 / 180 | 91% | 2.24 | 391 / 430 |
intestine | 100% | 650.01 | 966 / 966 | 91% | 2.26 | 479 / 527 |
kidney | 100% | 820.78 | 89 / 89 | 89% | 2.87 | 798 / 901 |
skin | 100% | 893.94 | 1806 / 1809 | 86% | 2.62 | 406 / 472 |
bladder | 100% | 632.29 | 21 / 21 | 83% | 1.93 | 420 / 504 |
uterus | 100% | 771.11 | 170 / 170 | 76% | 1.45 | 347 / 459 |
adrenal gland | 100% | 1037.90 | 258 / 258 | 75% | 1.66 | 173 / 230 |
liver | 100% | 1028.56 | 226 / 226 | 69% | 1.40 | 282 / 406 |
brain | 92% | 324.75 | 2428 / 2642 | 61% | 1.31 | 432 / 705 |
adipose | 100% | 961.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1132.85 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1179.05 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 2052.35 | 925 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 379.30 | 799 / 861 | 0% | 0 | 0 / 0 |
muscle | 81% | 191.01 | 647 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 1.50 | 35 / 45 |
lymph node | 0% | 0 | 0 / 0 | 69% | 1.36 | 20 / 29 |
eye | 0% | 0 | 0 / 0 | 44% | 0.83 | 35 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006032 | Biological process | chitin catabolic process |
GO_0009313 | Biological process | oligosaccharide catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005764 | Cellular component | lysosome |
GO_0004568 | Molecular function | chitinase activity |
GO_0008061 | Molecular function | chitin binding |
Gene name | CTBS |
Protein name | CTBS protein Di-N-acetylchitobiase (EC 3.2.1.-) Chitobiase |
Synonyms | CTB |
Description | FUNCTION: Involved in the degradation of asparagine-linked glycoproteins. Hydrolyze of N-acetyl-beta-D-glucosamine (1-4)N-acetylglucosamine chitobiose core from the reducing end of the bond, it requires prior cleavage by glycosylasparaginase. |
Accessions | ENST00000370630.6 F6X5H7 ENST00000465118.6 ENST00000370625.1 Q01459 Q8TC97 |